Moderna Could Seek Approval in November
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities https://t.co/dTBLH3iwbT— The Washington Post (@washingtonpost) October 22, 2020
Health Editor’s Note: The main issues other than safety and efficacy is that the vaccine/trials will be representative of the U.S. population. Recruitment has slowed the process but now there are 30,000 participants with 25% over 65, one fifth Hispanic, and 10% Black.
Pfizer, which is not a part of the Operation Warp Speed, a federal program to speed up COVID-19 vaccine research and production, also has a large trial in the works with 39,862 participants. Both the Moderna and Pfizer trials have given the second booster dose of vaccine…..Carol